Examinando por Autor "Torres Salas, Roimer"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Farmacorresistencia a drogas de primera línea en pacientes con tuberculosis de los distritos de la DIRIS Lima Sur, año 2014-2018
    (Universidad Privada Norbert Wiener, 2020-10-26) Torres Salas, Roimer; Caldas Herrera, Emma
    This study aimed to determine the percentage of drug resistance to first-line drugs in patients with tuberculosis from the DIRIS Lima Sur districts. The study was conducted between 2014 and 2018. The methodology was quantitative, descriptive, and retrospective. The design was non-experimental and cross-sectional. The sample included 573 patients with positive cultures. The results were based on sensitivity and resistance to isoniazid, with 21.5%. Resistance to rifampicin, ethambutol, and pyrazinamide was 8.2%. Age was higher in young people (8%), in adults (5%), and in older adults (1%). For ethambutol and pyrazinamide, the prevalence of resistance was higher in women (64.9%), while for women (14.5%). Regarding isoniazid resistance, women had 18% compared to 12% in men. By district, 20% of patients in Villa el Salvador were resistant to isoniazid, 9% to rifampicin, and 4% in Villa María del Triunfo. Regarding clinical history, 19% of patients with isoniazid resistance were never treated; 26.7% had previously been treated; 22.3% were symptomatic respiratory patients; and 15.4% were asymptomatic. Of those with abnormal X-rays, 14.3% were resistant to the drug, and 22% were resistant to normal X-rays.